title: Successful continuous-flow left ventricular assist device implantation with adjuvant tricuspid valve repair for advanced heart failure.
abstract: The prevalence of end-stage heart failure (HF) is on the increase, however, the availability of donor hearts remains limited. Left ventricular assist devices (LVADs) are increasingly being used for treating patients with end-stage HF. LVADs are not only used as a bridge to transplantation but also as a destination therapy. HeartMate II, a new-generation, continuous-flow LVAD (cf-LVAD), is currently an established treatment option for patients with HF. Technological progress and increasing implantation of cf-LVADs have significantly improved survival in patients with end-stage HF. Here we report a case of a patient with end-stage HF who was successfully supported using cf-LVAD implantation with adjuvant tricuspid valve repair in a general district hospital.
authors.affiliation: Department of Cardiac Surgery, Tungs' Taichung Metro-Harbor Hospital; Department of Biological Science and Technology, National Chiao-Tung University; Department of Surgery, National Defense Medical Centre, Taiwan. Email: jamesolee@yahoo.com.tw.
authors.forename: Chih-Hsien
authors.initials: CH
authors.lastname: Lee
authors.affiliation: Heart Centre, Cheng Hsin General Hospital, Taiwan.
authors.forename: Jeng
authors.initials: J
authors.lastname: Wei
mesh_terms: D000328:Adult; D058385:Cardiac Valve Annuloplasty; D006333:Heart Failure / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D006353:Heart-Assist Devices; D006439:Hemodynamics; D006801:Humans; D008297:Male; D011474:Prosthesis Design; D020127:Recovery of Function; D013997:Time Factors; D016896:Treatment Outcome; D014261:Tricuspid Valve / Q000503:physiopathology / Q000601:surgery*; D016277:Ventricular Function, Left